Towards predictive docking at aminergic G-protein coupled receptors
暂无分享,去创建一个
[1] T. A. Jones,et al. The Uppsala Electron-Density Server. , 2004, Acta crystallographica. Section D, Biological crystallography.
[2] Ian T. Crosby,et al. Homology Modeling and Docking Evaluation of Aminergic G Protein-Coupled Receptors , 2010, J. Chem. Inf. Model..
[3] J. Trujillo-Ferrara,et al. Molecular dynamics simulations to explore the active/inactive conformers of guinea pig β2 adrenoceptor for the selective design of agonists or antagonists , 2014 .
[4] Ruben Abagyan,et al. Status of GPCR modeling and docking as reflected by community-wide GPCR Dock 2010 assessment. , 2011, Structure.
[5] Laura López,et al. Progress in the structural prediction of G protein‐coupled receptors: D3 receptor in complex with eticlopride , 2011, Proteins.
[6] Gebhard F. X. Schertler,et al. Structure of a β1-adrenergic G-protein-coupled receptor , 2008, Nature.
[7] Federico D. Sacerdoti,et al. Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters , 2006, ACM/IEEE SC 2006 Conference (SC'06).
[8] J. Venter,et al. Site-directed mutagenesis of m1 muscarinic acetylcholine receptors: conserved aspartic acids play important roles in receptor function. , 1989, Molecular pharmacology.
[9] R. Stevens,et al. High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.
[10] Charles L. Brooks,et al. Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008 , 2009, Nature Reviews Drug Discovery.
[11] Stefano Moro,et al. Bridging Molecular Docking to Membrane Molecular Dynamics To Investigate GPCR-Ligand Recognition: The Human A2A Adenosine Receptor as a Key Study , 2014, J. Chem. Inf. Model..
[12] Ruben Abagyan,et al. Structure of the human histamine H1 receptor complex with doxepin , 2011, Nature.
[13] Vadim Cherezov,et al. A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. , 2008, Structure.
[14] R. Horuk,et al. I want a new drug: G-protein-coupled receptors in drug development. , 2006, Drug discovery today.
[15] Haruki Nakamura,et al. Announcing the worldwide Protein Data Bank , 2003, Nature Structural Biology.
[16] Gert Vriend,et al. Increasing the precision of comparative models with YASARA NOVA—a self‐parameterizing force field , 2002, Proteins.
[17] Ádám A. Kelemen,et al. A desirability function-based scoring scheme for selecting fragment-like class A aminergic GPCR ligands , 2014, Journal of Computer-Aided Molecular Design.
[18] R. Stevens,et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. , 2007, Science.
[19] D. Rognan,et al. Selective structure-based virtual screening for full and partial agonists of the beta2 adrenergic receptor. , 2008, Journal of medicinal chemistry.
[20] C. E. Peishoff,et al. A critical assessment of docking programs and scoring functions. , 2006, Journal of medicinal chemistry.
[21] L. Bačáková,et al. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors. , 1995, The Journal of pharmacology and experimental therapeutics.
[22] A. Kruse,et al. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist , 2011, Nature.
[23] Matthew P. Repasky,et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.
[24] James M. Anderson,et al. Experimental versus predicted affinities for ligand binding to estrogen receptor: iterative selection and rescoring of docked poses systematically improves the correlation , 2013, Journal of Computer-Aided Molecular Design.
[25] Martin Caffrey,et al. Membrane protein crystallization. , 2003, Journal of structural biology.
[26] J. Gready,et al. Combining docking and molecular dynamic simulations in drug design , 2006, Medicinal research reviews.
[27] K. Palczewski,et al. Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2000, Science.
[28] Gebhard F. X. Schertler,et al. Two distinct conformations of helix 6 observed in antagonist-bound structures of a β1-adrenergic receptor , 2011, Proceedings of the National Academy of Sciences.
[29] Woody Sherman,et al. Current Assessment of Docking into GPCR Crystal Structures and Homology Models: Successes, Challenges, and Guidelines , 2012, J. Chem. Inf. Model..
[30] R. Lefkowitz. Historical review: a brief history and personal retrospective of seven-transmembrane receptors. , 2004, Trends in pharmacological sciences.
[31] Anthony Nicholls,et al. Essential considerations for using protein-ligand structures in drug discovery. , 2012, Drug discovery today.
[32] M. Brann,et al. Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions. , 1993, Molecular pharmacology.
[33] M. Koliński,et al. Molecular interactions between fenoterol stereoisomers and derivatives and the β2-adrenergic receptor binding site studied by docking and molecular dynamics simulations , 2013, Journal of Molecular Modeling.
[34] Albert C. Pan,et al. Structure and Dynamics of the M3 Muscarinic Acetylcholine Receptor , 2012, Nature.
[35] Ruben Abagyan,et al. Advances in GPCR modeling evaluated by the GPCR Dock 2013 assessment: meeting new challenges. , 2014, Structure.
[36] R. Abagyan,et al. Conserved binding mode of human beta2 adrenergic receptor inverse agonists and antagonist revealed by X-ray crystallography. , 2010, Journal of the American Chemical Society.
[37] David S. Goodsell,et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..
[38] Santiago Vilar,et al. In Silico screening for agonists and blockers of the β2 adrenergic receptor: Implications of inactive and activated state structures , 2012, J. Comput. Chem..
[39] D. Frank Hsu,et al. Consensus Scoring Criteria for Improving Enrichment in Virtual Screening , 2005, J. Chem. Inf. Model..
[40] Nagarajan Vaidehi,et al. The role of conformational ensembles in ligand recognition in G-protein coupled receptors. , 2011, Journal of the American Chemical Society.
[41] Lingle Wang,et al. On achieving high accuracy and reliability in the calculation of relative protein–ligand binding affinities , 2012, Proceedings of the National Academy of Sciences.
[42] M. Murcko,et al. Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins. , 1999, Journal of medicinal chemistry.
[43] Kai Wang,et al. Identifying ligand binding sites and poses using GPU-accelerated Hamiltonian replica exchange molecular dynamics , 2013, Journal of Computer-Aided Molecular Design.
[44] David E. Gloriam,et al. G Protein- and Agonist-Bound Serotonin 5-HT2A Receptor Model Activated by Steered Molecular Dynamics Simulations , 2011, J. Chem. Inf. Model..
[45] David K. Chalmers,et al. Homology Modeling of Human Muscarinic Acetylcholine Receptors , 2014, J. Chem. Inf. Model..
[46] S J Wodak,et al. SFCHECK: a unified set of procedures for evaluating the quality of macromolecular structure-factor data and their agreement with the atomic model. , 1999, Acta crystallographica. Section D, Biological crystallography.
[47] Woody Sherman,et al. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments , 2013, Journal of Computer-Aided Molecular Design.
[48] Jonathan A. Javitch,et al. Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist , 2010, Science.
[49] R. Friesner,et al. Novel procedure for modeling ligand/receptor induced fit effects. , 2006, Journal of medicinal chemistry.
[50] Jessica Holien,et al. Improvements, trends, and new ideas in molecular docking: 2012–2013 in review , 2015, Journal of molecular recognition : JMR.